Trulieve Continues To Stand Out From The Cannabis Sector Pack

At the close of last week, the stock, which trades on the US OTC market was at US$12.65. It closed yesterday in Toronto at C$18.31, up more than 3.5% on the day.

Earlier last week, the Florida-based medical marijuana company released its first quarter earnings for 2020. The highlight: a 21% increase in revenues, which reached US$96 million, up from the previous quarter’s total of US$79 million, beating some analyst estimates.

Trulieve also reported a net income of US$14 million for the first quarter, which ended March 31. It’s cash holdings were pegged at US$100.8 million. “Our financial position continues to differentiate us in the market by providing flexibility to support both organic and external growth initiatives, which is increasingly important during these times,” said CEO Kim Rivers in a statement . She added:

“Trulieve’s execution of key fundamentals and financial discipline coupled with market share growth this quarter contributed to positive free cash flow, further strengthening our balance sheet and validating our financial stewardship.”

The latest financial report puts Trulieve in a small subset of cannabis companies—operators in the sector that are not showing massive losses.

Trulieve also recorded a last week as it opened its 50^th store. Located in Daytona Beach, the new outlet is one of the company’s biggest.

Trulieve is also showing its contrast with other cannabis companies in that it continues to expand its workforce, even during the COVID-19 pandemic. Since mid-March it has hired more than 500 people and is seeking to add about 300 more.

The company also reaffirmed its guidance, predicting it will hit revenues of between US$380 million and $400 million in the current fiscal year, up from 2019 total of $220 million.

Canopy Growth Update Friday

The world’s largest marijuana company, Canopy Growth (NYSE:CGC), (TSX:WEED) will host a conference call Friday to discuss its fourth quarter and full-year financial results.

Get The App

Join the millions of people who stay on top of global financial markets with Investing.com.

Download Now

Shares of the Ontario-based cannabis grower increased at the end of last week, gaining more than 6% to close at US$19.42 in New York and C$27.10 in Toronto. The bounce was attributed to the stock being given a buy rating from Bank of America analysts, who set the target price at US$21.44 (C$30), as it reinstated coverage of the pot stock.

Bank of America says despite the slower than expected development of the Canadian legal marijuana market, Canopy Growth is very well positioned as a leader in a market it considers will eventually see significant expansion.

The company’s third quarter results included net revenues of C$123.8 million (USD $93.36 million). The company has been steadily cutting its operating costs, and moved to slash its workforce by 800 positions due to the COVID-19 pandemic.